tradingkey.logo
tradingkey.logo
검색

Bausch + Lomb Corp

BLCO
관심 목록에 추가
16.540USD
-0.090-0.54%
종가 06/30, 16:00ET시세는 15분 지연됩니다
5.86B시가총액
손실P/E TTM

자세한 내용은 Bausch + Lomb Corp 회사

Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.

Bausch + Lomb Corp 정보

종목 코드 BLCO
회사 이름Bausch + Lomb Corp
상장일May 06, 2022
CEOSaunders (Brenton L)
직원 수13500
유형Ordinary Share
회계 연도 종료May 06
주소520 Applewood Crescent
도시VAUGHAN
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가Canada
우편 번호L4K 4B4
전화19082552864
웹사이트https://ir.bausch.com/
종목 코드 BLCO
상장일May 06, 2022
CEOSaunders (Brenton L)

Bausch + Lomb Corp의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
87.02K
-1.16%
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
72.80K
-18.77%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
57.52K
+62.90%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
27.66K
+57.27%
Mr. Sam A. Eldessouky
Mr. Sam A. Eldessouky
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Thomas W. Ross, Sr.
Mr. Thomas W. Ross, Sr.
Lead Independent Director
Lead Independent Director
--
--
Mrs. Nathalie Bernier
Mrs. Nathalie Bernier
Independent Director
Independent Director
--
--
Dr. Andrew Charles Von Eschenbach, M.D.
Dr. Andrew Charles Von Eschenbach, M.D.
Independent Director
Independent Director
--
--
Ms. Sarah B. Kavanagh
Ms. Sarah B. Kavanagh
Independent Director
Independent Director
--
--
Mr. John A. Paulson ,
Mr. John A. Paulson ,
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
87.02K
-1.16%
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
72.80K
-18.77%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
57.52K
+62.90%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
27.66K
+57.27%
Mr. Sam A. Eldessouky
Mr. Sam A. Eldessouky
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Thomas W. Ross, Sr.
Mr. Thomas W. Ross, Sr.
Lead Independent Director
Lead Independent Director
--
--

자주 묻는 질문

Bausch + Lomb Corp의 상위 5대 주주는 누구인가요?

Bausch + Lomb Corp의 상위 5대 주주는 다음과 같습니다: Mr. Luc Bonnefoy

Bausch + Lomb Corp(BLCO)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Bausch + Lomb Corp의 주식을 보유한 기관은 총 249곳이며, 이들이 보유한 주식의 총 가치는 약 40.30M로 전체 발행 주식의 11.30%를 차지합니다. 이는 2025Q4 대비 -25007155.00 증가한 수치입니다.

Bausch + Lomb Corp의 최대 수익원은 무엇인가요?

2026Q1 기준, Bausch + Lomb Corp의 Devices 부문이 가장 높은 매출을 기록했으며, 금액은 1.92B로 전체 매출의 37.68%를 차지했습니다.
KeyAI